ONKURE THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
ONKURE THERAPEUTICS, INC. (OKUR) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $836.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2026-08-04
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $836.00K.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $109.00K.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $22.00K.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $1.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value as first filed |
|---|---|---|
| 2026-06-30 | $836.00K 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $109.00K 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $22.00K 10-Q · filed 2026-08-04 | |
| 2024-12-31 | $1.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $16.00K 10-K · filed 2025-03-10 | $0.00 10-K · filed 2024-03-28 |
| 2023-09-30 | $19.17M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $14.01M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $11.87M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $907.00K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $729.00K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $334.00K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $379.00K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $13.53M 10-K · filed 2023-03-27 | |
| 2021-09-30 | $8.87M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $15.33M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $6.09M 10-Q · filed 2021-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |